Urinary disorders (blood urine present, bacterial test positive, and urinary tract infection) and cardiovascular disorders (electrocardiogram T wave abnormal and increased blood pressure diastolic) were unexpected adverse events for sclerostin inhibitors. The gene discussed is SOST; the disease is urinary tract infection.